2.The development of PET/CT in determining gross tumor target volume of esophageal carcinoma in precise radiotherapy
Wei ZHANG ; Yipeng SONG ; Cuifang JIANG
Chinese Journal of Nuclear Medicine and Molecular Imaging 2014;34(2):157-160
As the development of functional and molecular imaging,PET/CT gradually becomes one of methods in optimizing cancer radiotherapy treatment planning.Currently,numerous hospitals routinely use 18F-FDG PET/CT for the delineation of target volume in esophageal carcinoma (EC).However,the validity of 18F-FDG PET/CT in the delineation of target volume for EC is limited and needs further clinical validation.This review focuses on the value and validity of 18F-FDG PET/CT in the delineation of gross tumor target volume of EC primary lesions and regional lymph nodes.
3.Clinical Research of Tang Shen Ning in Treating Early Stage of Diabetic Nephropathy with Types of Deficiency of both Vital Energy and Yin and Collaterals Siltation and Stagnant
Yanbin GAO ; Huiling ZHAO ; Song GUAN ; Hui ZHOU ; Jidi GENG ; Peifeng XIE ; Cuifang ZHAO ; Xuezheng SHANG ; Qingchun HAO ;
China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(07):-
Objective: To observe the clinical therapeutic effect of Tang Shen Ning(TSN,a prescription of traditional Chinese medicine)for curing the early stage of diabetic nephropathy(DN).Methods: Adopting random and double-blind controlled trial methods,several indexes were observed in terms of uric micro-amount albumin excretion rate,creatinine clearance,hemorheology and platelet function et al.Results: TSN could significantly reduce urinary albumin,glomerulus's hyper-filtration,improve blood stream transform and inhibit platelet aggregation.Conclusion: TSN could protect renal functions during the early stage of DN.